Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences; Business Will Be Called Cytiva
Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences; Business Will Be Called Cytiva |
[31-March-2020] |
WASHINGTON, March 31, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of the Biopharma business from General Electric Company's (NYSE: GE) Life Sciences division. As part of Danaher, the business will be called Cytiva and will be a standalone operating company within Danaher's Life Sciences segment. ABOUT DANAHER View original content:http://www.prnewswire.com/news-releases/danaher-completes-acquisition-of-the-biopharma-business-of-general-electric-life-sciences-business-will-be-called-cytiva-301032965.html SOURCE Danaher Corporation | ||
Company Codes: NYSE:DHR, NYSE:GE |
© 2020 PR Newswire. All Rights Reserved.